Acquired progressive lymphangioma: Case report with partial response to imiquimod 5% cream. Issue 6 (21st September 2017)

• Record Type: Journal Article
• Authors: Salman, Andac; Sarac, Gonca; Can Kuru, Burce; Cinel, Leyla; Yucelten, Ayse Deniz; Ergun, Tulin
• Is Part Of: Pediatric dermatology. Volume 34:Issue 6(2017:Nov./Dec.)
• Page Start: e302
• Page End: e304
• Publication Date: 2017-09-21
• Subjects: dermatopathology -- hemangiomas/vascular tumors -- topical therapy; Pediatric dermatology -- Periodicals; Children -- Diseases -- Periodicals; 618.925
• DOI: 10.1111/pde.13283
• Languages: English
• ISSNs: 0736-8046

Abstract

Abstract: Acquired progressive lymphangioma (APL), or benign lymphangioendothelioma, is an unusual entity derived from vascular structures. Clinically and histopathologically it may resemble Kaposi's sarcoma and well‐differentiated angiosarcoma, causing a diagnostic problem. We report an individual with APL initially diagnosed with Kaposi's sarcoma who underwent unnecessary laboratory testing. Imiquimod 5% cream stopped the progression of the lesion. Awareness of this rare entity may prevent patients from undergoing excessive testing. Imiquimod may be used as a safe, effective treatment option.